USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	054558/0437			Pages:	4
		Recorded:	12/01/2020
Attorney Dkt #:	76230-28000.00
Conveyance:	CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).

Total properties: 14

Patent #:	9198898	Issue Dt:	12/01/2015	Application #:	14312942	Filing Dt:	06/24/2014
Publication #:	US20150057255	Pub Dt:	02/26/2015
Title:	USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS

Patent #:	9486439	Issue Dt:	11/08/2016	Application #:	14899255	Filing Dt:	12/17/2015
Publication #:	US20160143882	Pub Dt:	05/26/2016
Title:	USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS

Patent #:	9381188	Issue Dt:	07/05/2016	Application #:	14922684	Filing Dt:	10/26/2015
Publication #:	US20160038462	Pub Dt:	02/11/2016
Title:	USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS

Patent #:	9474741	Issue Dt:	10/25/2016	Application #:	15175358	Filing Dt:	06/07/2016
Publication #:	US20160279100	Pub Dt:	09/29/2016
Title:	USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS

Patent #:	9737507	Issue Dt:	08/22/2017	Application #:	15269792	Filing Dt:	09/19/2016
Publication #:	US20170065557	Pub Dt:	03/09/2017
Title:	USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS

Patent #:	9737508	Issue Dt:	08/22/2017	Application #:	15271103	Filing Dt:	09/20/2016
Publication #:	US20170065558	Pub Dt:	03/09/2017
Title:	USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS

Patent #:	9974769	Issue Dt:	05/22/2018	Application #:	15626001	Filing Dt:	06/16/2017
Publication #:	US20170348282	Pub Dt:	12/07/2017
Title:	USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS

Patent #:	9968588	Issue Dt:	05/15/2018	Application #:	15626002	Filing Dt:	06/16/2017
Publication #:	US20170348283	Pub Dt:	12/07/2017
Title:	USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS

Patent #:	10278952	Issue Dt:	05/07/2019	Application #:	15949843	Filing Dt:	04/10/2018
Publication #:	US20180325866	Pub Dt:	11/15/2018
Title:	USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS

Patent #:	10278953	Issue Dt:	05/07/2019	Application #:	15956102	Filing Dt:	04/18/2018
Publication #:	US20180325867	Pub Dt:	11/15/2018
Title:	USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS

Patent #:	NONE	Issue Dt:		Application #:	16312900	Filing Dt:	12/21/2018
Publication #:	US20190216779	Pub Dt:	07/18/2019
Title:	USE OF NEUROKININ-1 ANTAGONISTS TO TREAT A VARIETY OF PRURITIC CONDITIONS

Patent #:	10617671	Issue Dt:	04/14/2020	Application #:	16364075	Filing Dt:	03/25/2019
Publication #:	US20200054603	Pub Dt:	02/20/2020
Title:	USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS

Patent #:	10702499	Issue Dt:	07/07/2020	Application #:	16364078	Filing Dt:	03/25/2019
Publication #:	US20200054604	Pub Dt:	02/20/2020
Title:	USE OF NK-1 RECEPTOR ANTAGONISTS IN PRURITUS

Patent #:	11026920	Issue Dt:	06/08/2021	Application #:	16806752	Filing Dt:	03/02/2020
Publication #:	US20200306224	Pub Dt:	10/01/2020
Title:	USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS

Assignor

Exec Dt:

09/04/2020

Assignee

520 U.S. HIGHWAY 22, SUITE 204

BRIDGEWATER, NEW JERSEY 08807

Correspondence name and address
	WEI TANG
	MORRISON & FOERSTER LLP
	425 MARKET STREET
	SAN FRANCISCO, CA 94105

Search Results as of: 06/17/2024 01:46 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6